http://orcid.org/0000-0002-2468-6954
References
- Abd-Elbary A, Haider M, Sayed S. 2012. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression. Pharm Dev Technol. 17:62–73.
- Bani-Jaber A, Al-Aani L, Alkhatib H, Al-Khalidi B. 2011. Prolonged intragastric drug delivery mediated by Eudragit® E-carrageenan polyelectrolyte matrix tablets. AAPS PharmSciTech. 12(1):354–361.
- Conte U, Maggi L. 2000. A flexible technology for the linear, pulsative and delayed release drugs, allowing for easy accommodation of difficult in vitro targets. J Control Release. 64:8–263.
- Costa P, Sousa Lobo M. 2001. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Pharm Dev Technol. 27:81–811.
- Dash S, Murthy P, Nath L, Chowdhury P. 2010. Kinetic modeling on drug-release from controlled drug delivery systems. Acta Pol Pharm. 67(3):217–223.
- Graham H, Baker Y, Oblt A. 1963. Complex formation between hydrocolloids and tranquilizers and hypotensive agents. J Pharm Sci. 529:191–198.
- Grenha A, Gomes M, Rodrigues M, Santo V, Mano J, Neves N, Reis R. 2009. Development of new chitosan/carrageenan nanoparticles for drug delivery applications. J Biomed Mater Res. 92(4):1265–1272.
- Hampson F, Farndale A, Strugala V, Sykes Y, Jolliffe I, Dettmar P. 2005. Alginate rafts and their characterization. Int J Pharm. 294(1-2):137–147.
- Hampson FC, Jolliffe IG, Bakhtyari A, Taylor G, Sykes J, Johnstone LM, Dettmar PW. 2010. Alginate–antacid combinations: raft formation and gastricretention studies. Drug Dev Ind Pharm. 36(5):614–623.
- Johnson F, Craig D, Mercer A, Chauhan S. 1997. The effects of alginate molecular structure and formulation variables on the physical characteristics of alginate raft systems. Int J Pharm. 159(1):35–42.
- Kapadia C, Mane V. 2007. Raft-forming agents: antireflux formulations. Drug Dev Ind Pharm. 33(12):1350–1361.
- Khan MZI, Prebeg Ž, Kurjaković N. 1999. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymer I. Manipulation of drug-release using Eudragit L100-55 and Eudragit S100 combinations. J Control Release. 58(2):215–222.
- Malerba M, Ragnoli B. 2008. Ambroxol in the 21st century. Expert Opin Drug Metab Toxicol. 4(8):1119–1129.
- Mandel K, Daggy B, Brodie D, Jacoby H. 2000. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 14:669–690.
- Mudie D, Murray K, Hoad C, Pritchard S, Garnett M, Amidon G, Gowland P, Spiller R, Amidon G, Marciani L. 2014. Quantification of gastrointestinal liquid volumes and distribution following a 240 ml dose of water in the fasted state. Mol Pharmaceutics. 11(9):3039–3047.
- Prajapati V, Jani G, Khutliwala T, Zala B. 2013. Raft forming system-an upcoming approach of gastro-retentive drug delivery system. J Control Release. 168(2):151–165.
- Sentein C, Guizard B, Giraud S, Yé C, Ténégal F. 2009. Dispersion and stability of TiO2 nanoparticles synthesized by laser pyrolysis in aqueous suspensions. J Phys: Conf Ser. 170:012013.
- Signoretti EC, Sena CD, Dell'Utri A, Alimonti S. 1988. An investigation into eventual interactions between clenbuterol and some mucolytic drugs by differential scanning calorimetry. Drug Dev Ind Pharm. 14(9):1167–1184.
- Tonnesen H, Karlsen J. 2002. Alginate in drug delivery systems. Drug Dev Ind Pharm. 28:621–630.
- Vallar S, Houivet D, El Fallah J, Kervadec D, Haussonne J-M. 1999. Oxide slurries stability and powders dispersion: optimization with zeta potential and rheological measurements. J Eur Ceram Soc. 19(6–7):1017–1021.
- Vedha N, Begum Y, Devi R. 2012. Solid state modification for the enhancement of solubility of poorly soluble drug: carrageenan as carrier. Int J App Pharm. 2:1–7.